Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada · Delayed Price · Currency is CAD 5.10
+0.61 (13.59%)
Jun 30, 2026, 4:00 PM EST
Medexus Pharmaceuticals Market Cap
Medexus Pharmaceuticals has a market cap or net worth of CAD 161.47 million as of July 1, 2026. Its market cap has increased by 66.85% in one year.
Market Cap
161.47M
Enterprise Value
183.44M
Revenue
138.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.10
Market Cap Chart
Since December 27, 2013, Medexus Pharmaceuticals's market cap has increased from 32.21M to 161.47M, an increase of 401.35%. That is a compound annual growth rate of 13.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 161.47M | 70.98% |
| Dec 31, 2025 | 94.44M | 10.49% |
| Dec 31, 2024 | 85.47M | 41.48% |
| Dec 29, 2023 | 60.41M | 45.19% |
| Dec 30, 2022 | 41.61M | -17.74% |
| Dec 31, 2021 | 50.58M | -48.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 255.20M |
| Auxly Cannabis Group | 250.87M |
| Organigram Global | 205.53M |
| Cardiol Therapeutics | 174.06M |
| Cannara Biotech | 167.93M |
| BioSyent | 160.71M |
| Ascend Wellness Holdings | 143.99M |
| Grown Rogue International | 142.47M |